Associate Scientist
Denali Therapeutics
Associate Scientist
Denali Therapeutics
Biotech company developing neurodegenerative therapeutics
Denali Therapeutics Inc. is a biotechnology company pioneering a new class of biotherapeutics designed to cross the blood-brain barrier (BBB) using its proprietary TransportVehicle™ platform. With the first FDA-approved biologic specifically designed to cross the BBB, a clinically validated delivery platform and a growing portfolio of therapeutic candidates across all stages of development, we are advancing toward our goal of delivering effective medicines to transform the lives of people living with neurodegenerative diseases, lysosomal storage disorders and other serious diseases.
We invite you to consider an opportunity with Denali to help achieve our goal of delivering meaningful therapeutics to patients.
Key Responsibilities
Requirements
This compensation and benefits information is based on Denali’s good faith estimate as of the date of publication and may be modified in the future.
Denali is committed to its core company value of unity by creating a diverse and inclusive environment. We are proud to be an equal opportunity employer and do not discriminate against any employee or applicant for employment because of race, color, sex, age, national origin, religion, sexual orientation, gender identity and/or expression, status as a veteran, basis of disability, or any other federal, state, or local protected class.
Biotech company developing neurodegenerative therapeutics
Denali Therapeutics develops and partners to create molecular therapeutics for neurodegenerative diseases such as Alzheimer's, Parkinson's, and ALS. Its approach combines in-house research with collaborations to identify disease-driving pathways through genetics, pathology, and cell biology, then design drugs that interact with specific molecules to treat these conditions. Unlike companies that rely on a single discovery path, Denali pairs its own science with strategic partnerships to access new technologies and share development risks, enabling faster progress. The company's goal is to defeat neurodegenerative diseases and improve patient outcomes by advancing therapies from discovery to potential commercialization through licensing, milestones, and eventual sales.
Explore more opportunities at Denali Therapeutics